Share Twitter LinkedIn Facebook Email Dr. Evan Yu, MD of University of Washington School of Medicine notes that smoking does not predispose higher response rate to Atezolizumab according to the IMvigor210 data. ASCO 2016
ASH 2025 MDS/ALL Highlights: Verona Trial Lessons & CLEVER Pathway | Dr. Jeyakumar Acute Lymphoblastic Leukemia 5 Mins Read
Advancing Acute Lymphoblastic Leukemia Treatment with CAR-T Cells: Insights from Dr. Anjali Advani Acute Lymphoblastic Leukemia 3 Mins Read